Yvette Ellis

Cleveland Clinic FoundationCleveland, Ohio - 44195 (216-445-8454) The Cleveland Clinic FoundationCleveland, Ohio - 44195 (216-444-2520) |
- CLINICAL TRIALS 2
- CONDITIONS4
- INTERVENTIONS3
- SINCE2006

Safety Pharmacokinetics and Efficacy of an AT-III Concentrate.
January 2006 - January 2013

A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)
January 2009 - June 2018
Leukemia
Leukemia, Lymphocytic, Chronic, B-Cell
Leukemia, Lymphoid
Antithrombin III Deficiency
Placebo
Lenalidomide
Plasma-Derived At-Iii Concentrate



